| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | coumarin 7-hydroxylase activity | 1.08e-07 | 3 | 96 | 3 | GO:0008389 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 3.72e-06 | 7 | 96 | 3 | GO:0019770 | |
| GeneOntologyMolecularFunction | IgG binding | 1.73e-05 | 11 | 96 | 3 | GO:0019864 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.27e-05 | 38 | 96 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 3.77e-05 | 14 | 96 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 1.36e-04 | 4 | 96 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 2.03e-04 | 24 | 96 | 3 | GO:0008392 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.64e-04 | 118 | 96 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.90e-04 | 27 | 96 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 5.78e-04 | 34 | 96 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 6.30e-04 | 35 | 96 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 6.85e-04 | 36 | 96 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.88e-04 | 86 | 96 | 4 | GO:0005254 | |
| GeneOntologyMolecularFunction | calmodulin binding | 8.56e-04 | 230 | 96 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.24e-03 | 166 | 96 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.54e-03 | 103 | 96 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.69e-03 | 49 | 96 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.79e-03 | 50 | 96 | 3 | GO:0099095 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 1.15e-05 | 10 | 96 | 3 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 1.15e-05 | 10 | 96 | 3 | GO:0009804 | |
| GeneOntologyBiologicalProcess | negative regulation of type I hypersensitivity | 2.14e-05 | 2 | 96 | 2 | GO:0001811 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 2.70e-05 | 13 | 96 | 3 | GO:0001788 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 4.27e-05 | 15 | 96 | 3 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 4.27e-05 | 15 | 96 | 3 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of response to endoplasmic reticulum stress | 5.67e-05 | 45 | 96 | 4 | GO:1905898 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine maintenance | 7.58e-05 | 18 | 96 | 3 | GO:1902950 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transport | 7.58e-05 | 18 | 96 | 3 | GO:0044070 | |
| GeneOntologyBiologicalProcess | regulation of response to salt stress | 1.28e-04 | 4 | 96 | 2 | GO:1901000 | |
| GeneOntologyBiologicalProcess | negative regulation of hypersensitivity | 1.28e-04 | 4 | 96 | 2 | GO:0002884 | |
| GeneOntologyBiologicalProcess | regulation of cellular hyperosmotic salinity response | 1.28e-04 | 4 | 96 | 2 | GO:1900069 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 1.41e-04 | 22 | 96 | 3 | GO:0019373 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 2.00e-04 | 62 | 96 | 4 | GO:0038093 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 2.09e-04 | 25 | 96 | 3 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | 2.12e-04 | 5 | 96 | 2 | GO:1903381 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil apoptotic process | 2.12e-04 | 5 | 96 | 2 | GO:0033030 | |
| GeneOntologyBiologicalProcess | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 3.18e-04 | 6 | 96 | 2 | GO:0036483 | |
| GeneOntologyBiologicalProcess | dendritic spine maintenance | 3.62e-04 | 30 | 96 | 3 | GO:0097062 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 4.38e-04 | 136 | 96 | 5 | GO:0050764 | |
| GeneOntologyBiologicalProcess | Fc receptor-mediated immune complex endocytosis | 4.43e-04 | 7 | 96 | 2 | GO:0160006 | |
| GeneOntologyBiologicalProcess | regulation of chloride transport | 4.43e-04 | 7 | 96 | 2 | GO:2001225 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 4.50e-04 | 387 | 96 | 8 | GO:0050807 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 4.60e-04 | 77 | 96 | 4 | GO:0009583 | |
| GeneOntologyCellularComponent | myosin II filament | 6.24e-05 | 3 | 96 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | chloride channel complex | 1.37e-04 | 57 | 96 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | myosin complex | 1.57e-04 | 59 | 96 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 2.01e-04 | 25 | 96 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.83e-04 | 28 | 96 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.75e-04 | 223 | 96 | 6 | GO:0098862 | |
| MousePheno | abnormal intestinal lipid absorption | 2.52e-05 | 31 | 78 | 4 | MP:0005342 | |
| Domain | Cyt_P450_E_grp-I_CYP2A-like | 5.41e-07 | 4 | 97 | 3 | IPR008067 | |
| Domain | IQ | 3.38e-05 | 71 | 97 | 5 | PF00612 | |
| Domain | Myosin_head_motor_dom | 4.41e-05 | 38 | 97 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.41e-05 | 38 | 97 | 4 | PS51456 | |
| Domain | Myosin_head | 4.41e-05 | 38 | 97 | 4 | PF00063 | |
| Domain | MYSc | 4.41e-05 | 38 | 97 | 4 | SM00242 | |
| Domain | Myosin_N | 5.91e-05 | 15 | 97 | 3 | PF02736 | |
| Domain | Myosin_N | 5.91e-05 | 15 | 97 | 3 | IPR004009 | |
| Domain | IQ | 6.39e-05 | 81 | 97 | 5 | SM00015 | |
| Domain | HRDC | 7.98e-05 | 3 | 97 | 2 | SM00341 | |
| Domain | HRDC | 7.98e-05 | 3 | 97 | 2 | PS50967 | |
| Domain | HRDC | 7.98e-05 | 3 | 97 | 2 | PF00570 | |
| Domain | Myosin_tail_1 | 1.05e-04 | 18 | 97 | 3 | PF01576 | |
| Domain | Myosin_tail | 1.05e-04 | 18 | 97 | 3 | IPR002928 | |
| Domain | IQ_motif_EF-hand-BS | 1.06e-04 | 90 | 97 | 5 | IPR000048 | |
| Domain | IQ | 1.23e-04 | 93 | 97 | 5 | PS50096 | |
| Domain | Myosin-like_IQ_dom | 1.24e-04 | 19 | 97 | 3 | IPR027401 | |
| Domain | - | 1.24e-04 | 19 | 97 | 3 | 4.10.270.10 | |
| Domain | HRDC_dom | 1.59e-04 | 4 | 97 | 2 | IPR002121 | |
| Domain | HRDC-like | 2.64e-04 | 5 | 97 | 2 | IPR010997 | |
| Domain | Myosin_S1_N | 2.64e-04 | 5 | 97 | 2 | IPR008989 | |
| Domain | - | 4.37e-04 | 122 | 97 | 5 | 3.40.30.10 | |
| Domain | Thioredoxin | 5.49e-04 | 31 | 97 | 3 | PF00085 | |
| Domain | Thioredoxin-like_fold | 6.26e-04 | 132 | 97 | 5 | IPR012336 | |
| Domain | Prot_kinase_dom | 9.99e-04 | 489 | 97 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 1.06e-03 | 493 | 97 | 9 | PS50011 | |
| Domain | Thioredoxin_domain | 1.25e-03 | 41 | 97 | 3 | IPR013766 | |
| Domain | THIOREDOXIN_2 | 1.44e-03 | 43 | 97 | 3 | PS51352 | |
| Domain | Cyt_P450_E_grp-I | 1.65e-03 | 45 | 97 | 3 | IPR002401 | |
| Domain | Kinase-like_dom | 2.03e-03 | 542 | 97 | 9 | IPR011009 | |
| Domain | CUB | 2.64e-03 | 53 | 97 | 3 | PS01180 | |
| Domain | Cyt_P450_CS | 2.64e-03 | 53 | 97 | 3 | IPR017972 | |
| Domain | - | 3.06e-03 | 16 | 97 | 2 | 1.10.506.10 | |
| Domain | CYTOCHROME_P450 | 3.24e-03 | 57 | 97 | 3 | PS00086 | |
| Domain | CUB_dom | 3.24e-03 | 57 | 97 | 3 | IPR000859 | |
| Domain | - | 3.41e-03 | 58 | 97 | 3 | 1.10.630.10 | |
| Domain | p450 | 3.41e-03 | 58 | 97 | 3 | PF00067 | |
| Domain | Pkinase | 3.71e-03 | 381 | 97 | 7 | PF00069 | |
| Domain | Cyt_P450 | 3.75e-03 | 60 | 97 | 3 | IPR001128 | |
| Domain | LH2 | 3.87e-03 | 18 | 97 | 2 | SM00308 | |
| Domain | RasGAP_dom | 3.87e-03 | 18 | 97 | 2 | IPR001936 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.13e-05 | 11 | 73 | 3 | M27130 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 2.73e-05 | 34 | 73 | 4 | M27183 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.83e-05 | 12 | 73 | 3 | MM14847 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.03e-04 | 18 | 73 | 3 | MM14841 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 1.22e-04 | 19 | 73 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.22e-04 | 19 | 73 | 3 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.43e-04 | 20 | 73 | 3 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.66e-04 | 21 | 73 | 3 | M27494 | |
| Pathway | REACTOME_XENOBIOTICS | 2.19e-04 | 23 | 73 | 3 | M5372 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 2.19e-04 | 23 | 73 | 3 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.49e-04 | 24 | 73 | 3 | M2243 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS | 2.62e-04 | 5 | 73 | 2 | M47808 | |
| Pathway | REACTOME_XENOBIOTICS | 2.82e-04 | 25 | 73 | 3 | MM14846 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 4.42e-04 | 29 | 73 | 3 | M27309 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.69e-04 | 70 | 73 | 4 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 6.02e-04 | 132 | 73 | 5 | M11355 | |
| Pubmed | Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. | 2.17e-08 | 3 | 98 | 3 | 31645370 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8297477 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8188299 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8250953 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 2703500 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 22217847 | ||
| Pubmed | Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. | 2.17e-08 | 3 | 98 | 3 | 22890016 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 26133275 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 3346244 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 2733794 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8484736 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 1417950 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 24045421 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 32987105 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 2765478 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 2415518 | ||
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 2.17e-08 | 3 | 98 | 3 | 24586589 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CUL4A GABRE CDS1 MYH10 TRIO MYCBP2 TTF1 NPLOC4 BPTF EPS15L1 INTS2 MYH14 TXNL4B EFHD1 TLL1 SCARB1 CKAP2 EIF4G3 ZMYM4 | 3.07e-08 | 1489 | 98 | 19 | 28611215 |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 10490589 | ||
| Pubmed | Two steroid 15 alpha-hydroxylase genes and a homologous gene family in mice. | 8.66e-08 | 4 | 98 | 3 | 1970547 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 9408084 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 7565685 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 19309690 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 20439936 | ||
| Pubmed | Copy number, linkage disequilibrium and disease association in the FCGR locus. | 2.16e-07 | 5 | 98 | 3 | 20508037 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 7668294 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 8587134 | ||
| Pubmed | CCPG1 TRIO TUBGCP2 LETM1 NPLOC4 AKAP12 LACTB NSD3 JAK1 EPS15L1 ZNHIT6 SCARB1 | 5.71e-07 | 689 | 98 | 12 | 36543142 | |
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 5.97e-07 | 57 | 98 | 5 | 17208939 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 9630227 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 14630516 | ||
| Pubmed | RANBP2 EXOSC10 TRIO KALRN MYCBP2 RIOK3 AKAP12 MYH14 UGP2 ZMYM4 | 1.48e-06 | 497 | 98 | 10 | 23414517 | |
| Pubmed | 1.78e-06 | 202 | 98 | 7 | 24639526 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 37838304 | ||
| Pubmed | EXOSC10 CCPG1 TAPT1 MYCBP2 KIAA1549 ZFC3H1 PLXNB2 LETM1 AKAP12 LACTB TXN BLM ANO6 PPA2 CKAP2 EIF4G3 | 3.98e-06 | 1487 | 98 | 16 | 33957083 | |
| Pubmed | 4.69e-06 | 12 | 98 | 3 | 8424456 | ||
| Pubmed | Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. | 7.86e-06 | 2 | 98 | 2 | 23616574 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19284648 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 17548594 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25904149 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21078890 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 33616086 | ||
| Pubmed | Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model. | 7.86e-06 | 2 | 98 | 2 | 33861790 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 12325023 | ||
| Pubmed | FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. | 7.86e-06 | 2 | 98 | 2 | 20179765 | |
| Pubmed | Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression. | 7.86e-06 | 2 | 98 | 2 | 24509813 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21477339 | ||
| Pubmed | Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia. | 7.86e-06 | 2 | 98 | 2 | 32684632 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11983693 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 34248948 | ||
| Pubmed | Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB. | 7.86e-06 | 2 | 98 | 2 | 10201978 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 20083655 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2531080 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 2138787 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8069908 | ||
| Pubmed | Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. | 7.86e-06 | 2 | 98 | 2 | 8824160 | |
| Pubmed | Regulation of allograft survival by inhibitory FcγRIIb signaling. | 7.86e-06 | 2 | 98 | 2 | 23150718 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 30876690 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29597194 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21395539 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21357255 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24366619 | ||
| Pubmed | Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions. | 7.86e-06 | 2 | 98 | 2 | 12162851 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1302041 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8395817 | ||
| Pubmed | Differences in endocytosis mediated by FcγRIIA and FcγRIIB2. | 7.86e-06 | 2 | 98 | 2 | 21945020 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16925577 | ||
| Pubmed | Absence of cytochrome P450 2A5 enhances alcohol-induced liver injury in mice. | 7.86e-06 | 2 | 98 | 2 | 25804444 | |
| Pubmed | FcγRIIb on liver sinusoidal endothelium clears small immune complexes. | 7.86e-06 | 2 | 98 | 2 | 23053513 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1520280 | ||
| Pubmed | A complementary DNA clone for a macrophage-lymphocyte Fc receptor. | 7.86e-06 | 2 | 98 | 2 | 3024012 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23917075 | ||
| Pubmed | Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1. | 7.86e-06 | 2 | 98 | 2 | 14990693 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 10704470 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 3161943 | ||
| Pubmed | Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice. | 7.86e-06 | 2 | 98 | 2 | 38069267 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 10704418 | ||
| Pubmed | CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele. | 7.86e-06 | 2 | 98 | 2 | 16636685 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 27902773 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 37539049 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23897982 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16757681 | ||
| Pubmed | FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells. | 7.86e-06 | 2 | 98 | 2 | 28849025 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23053716 | ||
| Pubmed | Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells. | 7.86e-06 | 2 | 98 | 2 | 15843524 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29190833 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18957413 | ||
| Pubmed | Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. | 7.86e-06 | 2 | 98 | 2 | 19644866 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21969314 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25267791 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24869670 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 30610165 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 1910686 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24654803 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 6974691 | ||
| Pubmed | Circadian Regulation of Hepatic Cytochrome P450 2a5 by Peroxisome Proliferator-Activated Receptor γ. | 7.86e-06 | 2 | 98 | 2 | 30154104 | |
| Pubmed | Expression of CYP2A genes in human liver and extrahepatic tissues. | 7.86e-06 | 2 | 98 | 2 | 10353262 | |
| Pubmed | Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function. | 7.86e-06 | 2 | 98 | 2 | 26941575 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 15634937 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23818610 | ||
| Interaction | CYP2A7 interactions | 1.12e-07 | 3 | 98 | 3 | int:CYP2A7 | |
| Cytoband | 6q12 | 1.01e-03 | 22 | 98 | 2 | 6q12 | |
| Cytoband | 1q23 | 1.11e-03 | 23 | 98 | 2 | 1q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q12 | 1.42e-03 | 26 | 98 | 2 | chr6q12 | |
| GeneFamily | Myosin heavy chains | 1.87e-05 | 15 | 64 | 3 | 1098 | |
| GeneFamily | Cytochrome P450 family 2 | 2.55e-04 | 35 | 64 | 3 | 1001 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.26e-03 | 15 | 64 | 2 | 26 | |
| ToppCell | 18-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 1.08e-08 | 192 | 98 | 8 | 9fae988ecd2ef1231bfd42a678a4903517694cbe | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Club|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.26e-08 | 196 | 98 | 8 | 4e4c632db73b1340d80bf40a7657cb4821084d3c | |
| ToppCell | Ciliated_cells-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-07 | 170 | 98 | 7 | 3d3a03979014df3a05c49be18010c6b94d786707 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 1.79e-07 | 185 | 98 | 7 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.22e-07 | 191 | 98 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 193 | 98 | 7 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.47e-07 | 194 | 98 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.33e-07 | 145 | 98 | 6 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-06 | 181 | 98 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.22e-06 | 183 | 98 | 6 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.54e-06 | 186 | 98 | 6 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.54e-06 | 186 | 98 | 6 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 3.76e-06 | 188 | 98 | 6 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.88e-06 | 189 | 98 | 6 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.88e-06 | 189 | 98 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.88e-06 | 189 | 98 | 6 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.12e-06 | 191 | 98 | 6 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.37e-06 | 193 | 98 | 6 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 193 | 98 | 6 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 194 | 98 | 6 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 194 | 98 | 6 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.78e-06 | 196 | 98 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | normal_Lung-Epithelial_cells-Club|Epithelial_cells / Location, Cell class and cell subclass | 5.06e-06 | 198 | 98 | 6 | a9d0109ca05eb3e9c588f9677ec471dd5c092a75 | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-06 | 199 | 98 | 6 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.21e-06 | 199 | 98 | 6 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 8.77e-06 | 126 | 98 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.91e-05 | 148 | 98 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 162 | 98 | 5 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 166 | 98 | 5 | 2e4cb4056e6b0c43290a5588ff525f5f05b8beee | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.31e-05 | 166 | 98 | 5 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-D_(AT2)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-05 | 166 | 98 | 5 | eb8d972326a734549675307e411fc795af66da70 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-05 | 167 | 98 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.41e-05 | 167 | 98 | 5 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 168 | 98 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.03e-05 | 173 | 98 | 5 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-05 | 173 | 98 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.26e-05 | 175 | 98 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.26e-05 | 175 | 98 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | Posterior_cortex-Macroglia|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 175 | 98 | 5 | 8bc7a3856d04692989b2a1675ea6d9392261d55a | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.50e-05 | 177 | 98 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | Adult-Epithelial-club_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.62e-05 | 178 | 98 | 5 | 35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.62e-05 | 178 | 98 | 5 | 5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb | |
| ToppCell | Adult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor | 4.75e-05 | 179 | 98 | 5 | 1fc1f252ca943a2f649d1e627f56acbf15f8e058 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.75e-05 | 179 | 98 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.75e-05 | 179 | 98 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-05 | 180 | 98 | 5 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 180 | 98 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.00e-05 | 181 | 98 | 5 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.13e-05 | 182 | 98 | 5 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.13e-05 | 182 | 98 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 5.27e-05 | 183 | 98 | 5 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 5.27e-05 | 183 | 98 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 5.27e-05 | 183 | 98 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.41e-05 | 184 | 98 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 5.55e-05 | 185 | 98 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.55e-05 | 185 | 98 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 5.84e-05 | 187 | 98 | 5 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| ToppCell | VE-Treg-CD4_Treg|VE / Condition, Cell_class and T cell subcluster | 5.99e-05 | 188 | 98 | 5 | fa88ceb336e30de3585e62608527a0d44df74190 | |
| ToppCell | 15-Distal-Epithelial-Secretory_progenitor|Distal / Age, Tissue, Lineage and Cell class | 5.99e-05 | 188 | 98 | 5 | 9a64fb07de611de38d6f24673feb3b81a5e85384 | |
| ToppCell | VE-Treg|VE / Condition, Cell_class and T cell subcluster | 5.99e-05 | 188 | 98 | 5 | ef048517dfe2fc995d13eb1f08106a487354a4cc | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 6.14e-05 | 189 | 98 | 5 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 6.14e-05 | 189 | 98 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 6.14e-05 | 189 | 98 | 5 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.30e-05 | 190 | 98 | 5 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 190 | 98 | 5 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 190 | 98 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.45e-05 | 191 | 98 | 5 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 6.45e-05 | 191 | 98 | 5 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 6.45e-05 | 191 | 98 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-05 | 191 | 98 | 5 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.45e-05 | 191 | 98 | 5 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | COVID-19-kidney-Stressed_EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 191 | 98 | 5 | d35aa842b813ea0eff7362abc894cca4e86b2fb2 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-05 | 191 | 98 | 5 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | 15-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 6.45e-05 | 191 | 98 | 5 | 9359d8c6b00f8977848986baf3c950157adf4c9a | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 6.45e-05 | 191 | 98 | 5 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.45e-05 | 191 | 98 | 5 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 6.45e-05 | 191 | 98 | 5 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 6.61e-05 | 192 | 98 | 5 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 192 | 98 | 5 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 192 | 98 | 5 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Club|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 192 | 98 | 5 | 044c7ae56da17cacf2705efa8ac2c8aeba6cfeee | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 192 | 98 | 5 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 6.61e-05 | 192 | 98 | 5 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 6.61e-05 | 192 | 98 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | 25bdc557055b5bce6a21f8696b48e991c696b979 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 0208fcd8ea4662f40fc2c072ac220d97823eec12 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-05 | 193 | 98 | 5 | 04d47ba7cc1f19f1ffb18d9e68469e75063697cf | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 6.78e-05 | 193 | 98 | 5 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.78e-05 | 193 | 98 | 5 | bd0027fa97de41ae22ff64a61c8e217496f122ca | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 6.78e-05 | 193 | 98 | 5 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.78e-05 | 193 | 98 | 5 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 6.78e-05 | 193 | 98 | 5 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.95e-05 | 194 | 98 | 5 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.95e-05 | 194 | 98 | 5 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.95e-05 | 194 | 98 | 5 | 4199900d16623eca02d674d5ada7f0989e47955e | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.95e-05 | 194 | 98 | 5 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| Drug | 2'-methoxyacetophenone | 7.50e-08 | 3 | 97 | 3 | CID000068481 | |
| Drug | MDL 20,610 | 7.45e-07 | 5 | 97 | 3 | CID000128209 | |
| Drug | TAN-1030A | 1.49e-06 | 6 | 97 | 3 | CID009576886 | |
| Drug | AC1MHTIN | 2.59e-06 | 7 | 97 | 3 | CID003011133 | |
| Drug | TAN-999 | 2.59e-06 | 7 | 97 | 3 | CID000130283 | |
| Drug | Intravenous Immunoglobulin | 4.13e-06 | 8 | 97 | 3 | DB00028 | |
| Drug | AC1NSK5W | 6.18e-06 | 9 | 97 | 3 | CID005311182 | |
| Drug | Palivizumab | 8.80e-06 | 10 | 97 | 3 | DB00110 | |
| Drug | Denny-Jaffe reagent | 8.80e-06 | 10 | 97 | 3 | CID003035979 | |
| Drug | Bevacizumab | 1.21e-05 | 11 | 97 | 3 | DB00112 | |
| Drug | Tositumomab | 1.21e-05 | 11 | 97 | 3 | DB00081 | |
| Drug | Alemtuzumab | 1.21e-05 | 11 | 97 | 3 | DB00087 | |
| Drug | Efalizumab | 1.21e-05 | 11 | 97 | 3 | DB00095 | |
| Drug | Alefacept | 1.21e-05 | 11 | 97 | 3 | DB00092 | |
| Drug | Daclizumab | 1.60e-05 | 12 | 97 | 3 | DB00111 | |
| Drug | Natalizumab | 1.60e-05 | 12 | 97 | 3 | DB00108 | |
| Drug | Rituximab | 1.60e-05 | 12 | 97 | 3 | DB00073 | |
| Drug | Ibritumomab | 1.60e-05 | 12 | 97 | 3 | DB00078 | |
| Drug | Adalimumab | 1.60e-05 | 12 | 97 | 3 | DB00051 | |
| Drug | Gemtuzumab ozogamicin | 1.60e-05 | 12 | 97 | 3 | DB00056 | |
| Drug | Cetuximab | 1.60e-05 | 12 | 97 | 3 | DB00002 | |
| Drug | propargyl ether | 1.80e-05 | 2 | 97 | 2 | ctd:C531209 | |
| Drug | Hempa | 1.80e-05 | 2 | 97 | 2 | ctd:D006492 | |
| Drug | nicotine imine | 1.80e-05 | 2 | 97 | 2 | ctd:C034629 | |
| Drug | alpha-nicotyrine | 1.80e-05 | 2 | 97 | 2 | ctd:C008615 | |
| Drug | N-nitrosoguvacoline | 1.80e-05 | 2 | 97 | 2 | ctd:C036676 | |
| Drug | Trastuzumab | 2.08e-05 | 13 | 97 | 3 | DB00072 | |
| Drug | Basiliximab | 2.08e-05 | 13 | 97 | 3 | DB00074 | |
| Drug | C20H32O4 | 2.09e-05 | 78 | 97 | 5 | CID000001440 | |
| Drug | Abciximab | 2.64e-05 | 14 | 97 | 3 | DB00054 | |
| Drug | Etanercept | 2.64e-05 | 14 | 97 | 3 | DB00005 | |
| Drug | N-nitrosomethylaniline | 2.64e-05 | 14 | 97 | 3 | CID000011957 | |
| Drug | PD 0332991 | 3.29e-05 | 15 | 97 | 3 | CID005330286 | |
| Drug | Muromonab | 3.29e-05 | 15 | 97 | 3 | DB00075 | |
| Drug | AC1L9LSE | 4.03e-05 | 16 | 97 | 3 | CID000448272 | |
| Drug | 2cgx | 5.84e-05 | 18 | 97 | 3 | CID001548380 | |
| Drug | formycin triphosphate | 6.63e-05 | 51 | 97 | 4 | CID000122274 | |
| Drug | mepivacaine | 6.63e-05 | 51 | 97 | 4 | CID000004062 | |
| Drug | R13-1 | 6.91e-05 | 19 | 97 | 3 | CID000009666 | |
| Drug | Loestrin | 9.43e-05 | 21 | 97 | 3 | CID000062925 | |
| Drug | N'-nitrosoanatabine | 1.07e-04 | 4 | 97 | 2 | ctd:C032978 | |
| Drug | NMPA | 1.07e-04 | 4 | 97 | 2 | CID000132101 | |
| Drug | NSC35549 | 1.09e-04 | 22 | 97 | 3 | CID000411697 | |
| Drug | AC1Q5JRE | 1.09e-04 | 22 | 97 | 3 | CID000188349 | |
| Drug | purealin | 1.10e-04 | 58 | 97 | 4 | CID006419303 | |
| Drug | 1,1-dichloroethylene | 1.26e-04 | 60 | 97 | 4 | CID000006366 | |
| Drug | 8-MOP | 1.51e-04 | 118 | 97 | 5 | CID000004114 | |
| Drug | chlorzoxazone | 1.52e-04 | 63 | 97 | 4 | CID000002733 | |
| Drug | benzyl selenocyanate | 1.78e-04 | 5 | 97 | 2 | ctd:C054108 | |
| Drug | N-methyl-N-2-(methylsulfinyl)ethylpropionic acid amide | 1.78e-04 | 5 | 97 | 2 | ctd:C062567 | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 4133_UP | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 3213_DN | |
| Drug | eye gene | 1.82e-04 | 369 | 97 | 8 | CID000004782 | |
| Drug | Hecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 7175_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; HL60; HG-U133A | 1.89e-04 | 195 | 97 | 6 | 1979_DN | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 3327_UP | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; HL60; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2465_UP | |
| Drug | BP-9,10-oxide | 2.04e-04 | 27 | 97 | 3 | CID000037456 | |
| Drug | Brn 4136738 | 2.04e-04 | 27 | 97 | 3 | CID000050331 | |
| Drug | C14845 | 2.04e-04 | 27 | 97 | 3 | CID011954064 | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6838_DN | |
| Drug | 9-OH-BaP-4,5-oxide | 2.27e-04 | 28 | 97 | 3 | CID000115064 | |
| Drug | 4-bromophenol | 2.29e-04 | 70 | 97 | 4 | CID000007808 | |
| Drug | austin | 2.29e-04 | 70 | 97 | 4 | CID000430632 | |
| Drug | prednisolone phosphate | 2.66e-04 | 6 | 97 | 2 | CID000004896 | |
| Drug | CDPC | 2.66e-04 | 6 | 97 | 2 | CID000164786 | |
| Drug | menthofuran | 2.66e-04 | 6 | 97 | 2 | ctd:C054487 | |
| Drug | acenaphthene-1-ol | 2.66e-04 | 6 | 97 | 2 | ctd:C023723 | |
| Drug | AC1L196J | 2.66e-04 | 6 | 97 | 2 | CID000000415 | |
| Drug | N'-nitrosoanabasine | 2.66e-04 | 6 | 97 | 2 | ctd:C010257 | |
| Drug | maltos | 2.78e-04 | 393 | 97 | 8 | CID000000294 | |
| Drug | 19-hydroxytestosterone | 2.80e-04 | 30 | 97 | 3 | CID000150968 | |
| Drug | 11-H-14,15-EETA | 2.80e-04 | 30 | 97 | 3 | CID011954058 | |
| Disease | malaria (implicated_via_orthology) | 1.25e-08 | 9 | 95 | 4 | DOID:12365 (implicated_via_orthology) | |
| Disease | plexin-B2 measurement | 2.68e-06 | 9 | 95 | 3 | EFO_0021867 | |
| Disease | Ashkenazi Jewish disorders | 5.24e-06 | 11 | 95 | 3 | cv:CN118946 | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 1.13e-05 | 43 | 95 | 4 | DOID:9074 (implicated_via_orthology) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 2.13e-05 | 17 | 95 | 3 | EFO_0021969 | |
| Disease | CYSTIC FIBROSIS | 3.07e-05 | 3 | 95 | 2 | 219700 | |
| Disease | Cystic fibrosis | 3.07e-05 | 3 | 95 | 2 | cv:C0010674 | |
| Disease | total sitosterol measurement | 3.07e-05 | 3 | 95 | 2 | EFO_0020965 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 7.06e-05 | 25 | 95 | 3 | EFO_0021970 | |
| Disease | alkaline phosphatase measurement | CYP2A6 CYP2A7 SAMD9 BCAS1 SLCO1B1 JAK1 FCGR2C MYO3A FCGR2B TXNL4B UNC13C EIF4G3 | 1.02e-04 | 1015 | 95 | 12 | EFO_0004533 |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.02e-04 | 5 | 95 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | Werner syndrome (implicated_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | response to bevacizumab, Proteinuria | 1.02e-04 | 5 | 95 | 2 | EFO_0005943, HP_0000093 | |
| Disease | serum albumin measurement | CYP2A6 CYP2A7 EXOSC10 COBLL1 FCGR2C FCGR2A FCGR2B TXNL4B QSOX2 | 1.26e-04 | 592 | 95 | 9 | EFO_0004535 |
| Disease | SYSTEMIC LUPUS ERYTHEMATOSUS | 1.53e-04 | 6 | 95 | 2 | 152700 | |
| Disease | uric acid measurement | 1.58e-04 | 610 | 95 | 9 | EFO_0004761 | |
| Disease | serum non-albumin protein measurement | 1.70e-04 | 361 | 95 | 7 | EFO_0004568 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 2.13e-04 | 7 | 95 | 2 | EFO_0008211 | |
| Disease | lymphoid leukemia (is_implicated_in) | 2.13e-04 | 7 | 95 | 2 | DOID:1037 (is_implicated_in) | |
| Disease | Pulmonary Cystic Fibrosis | 3.64e-04 | 9 | 95 | 2 | C0392164 | |
| Disease | Fibrocystic Disease of Pancreas | 3.64e-04 | 9 | 95 | 2 | C1527396 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 4.04e-04 | 107 | 95 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | Colorectal Carcinoma | 4.41e-04 | 702 | 95 | 9 | C0009402 | |
| Disease | Ciliopathies | 4.48e-04 | 110 | 95 | 4 | C4277690 | |
| Disease | non-high density lipoprotein cholesterol measurement | 4.94e-04 | 713 | 95 | 9 | EFO_0005689 | |
| Disease | Systemic lupus erythematosus | 5.54e-04 | 11 | 95 | 2 | cv:C0024141 | |
| Disease | Cystic Fibrosis | 5.54e-04 | 11 | 95 | 2 | C0010674 | |
| Disease | nicotine metabolite ratio | 6.63e-04 | 12 | 95 | 2 | EFO_0007794 | |
| Disease | response to statin | 7.92e-04 | 56 | 95 | 3 | GO_0036273 | |
| Disease | triglycerides in LDL measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0022320 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 1.05e-03 | 15 | 95 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | autoimmune thrombocytopenic purpura (is_implicated_in) | 1.05e-03 | 15 | 95 | 2 | DOID:8924 (is_implicated_in) | |
| Disease | Hepatitis C | 1.05e-03 | 15 | 95 | 2 | C0019196 | |
| Disease | superior parietal cortex volume measurement | 1.05e-03 | 15 | 95 | 2 | EFO_0010330 | |
| Disease | X-17654 measurement | 1.05e-03 | 15 | 95 | 2 | EFO_0800784 | |
| Disease | phospholipids in large VLDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022322 | |
| Disease | Malaria, susceptibility to | 1.20e-03 | 16 | 95 | 2 | cv:C1970028 | |
| Disease | – | 1.20e-03 | 16 | 95 | 2 | 611162 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.53e-03 | 153 | 95 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement | 1.55e-03 | 260 | 95 | 5 | EFO_0008317 | |
| Disease | caffeine metabolite measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0007872 | |
| Disease | Malaria | 1.88e-03 | 20 | 95 | 2 | C0024530 | |
| Disease | Nonsyndromic genetic hearing loss | 1.92e-03 | 76 | 95 | 3 | cv:C5680182 | |
| Disease | cystatin C measurement | 1.93e-03 | 402 | 95 | 6 | EFO_0004617 | |
| Disease | serum alanine aminotransferase measurement | 1.96e-03 | 869 | 95 | 9 | EFO_0004735 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.07e-03 | 166 | 95 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | metabolite measurement | 2.24e-03 | 560 | 95 | 7 | EFO_0004725 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 2.27e-03 | 22 | 95 | 2 | EFO_0021115 | |
| Disease | Nonsyndromic Deafness | 2.30e-03 | 81 | 95 | 3 | C3711374 | |
| Disease | Leukemia, Myelocytic, Acute | 2.40e-03 | 173 | 95 | 4 | C0023467 | |
| Disease | Malignant neoplasm of breast | 2.41e-03 | 1074 | 95 | 10 | C0006142 | |
| Disease | monocyte percentage of leukocytes | 2.50e-03 | 731 | 95 | 8 | EFO_0007989 | |
| Disease | aspartate aminotransferase measurement | CYP2A6 KALRN COBLL1 FCGR2C FCGR2A FCGR2B TXNL4B EFHD1 SCARB1 | 2.56e-03 | 904 | 95 | 9 | EFO_0004736 |
| Disease | malaria (is_implicated_in) | 2.70e-03 | 24 | 95 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | urinary albumin to creatinine ratio | 2.71e-03 | 179 | 95 | 4 | EFO_0007778 | |
| Disease | serum gamma-glutamyl transferase measurement | 2.75e-03 | 914 | 95 | 9 | EFO_0004532 | |
| Disease | corpus collosum mid-posterior volume measurement | 2.93e-03 | 25 | 95 | 2 | EFO_0010300 | |
| Disease | mean corpuscular hemoglobin concentration | CUL4A SAMD9 KALRN COBLL1 SLCO1B1 NPLOC4 TXN FCGR2B SCARB1 EIF4G3 | 2.96e-03 | 1105 | 95 | 10 | EFO_0004528 |
| Disease | nevus count, cutaneous melanoma | 3.20e-03 | 91 | 95 | 3 | EFO_0000389, EFO_0004632 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFKAQGVAIKFGKFS | 526 | Q15361 | |
| ASFENKFKSEAKENG | 381 | A8MVM7 | |
| RFKEAFSKAAQQTKG | 261 | P55087 | |
| GSATDDFFKKQTKND | 671 | Q9UBC2 | |
| FSFSACKFNVQKSKE | 501 | Q8NEM8 | |
| GFKRAFKIKDFANTI | 376 | Q92903 | |
| ETKKQSFKQTGEFGE | 681 | P13569 | |
| SFKQTGEFGEKRKNS | 686 | P13569 | |
| FLNEKGQFKKSDAFV | 416 | P11509 | |
| FFENFKNKDIQSGEA | 66 | Q32M84 | |
| LQKKGEEDQKSFFEF | 141 | O60242 | |
| QANDIGFKKVFKFVG | 166 | Q02952 | |
| LVKVTFFQNGKSQKF | 151 | P12318 | |
| VKVTFFQNGKSKKFS | 161 | P31994 | |
| NDVFAKFSAFIKNTK | 571 | Q96NY7 | |
| EDFKTTNPSKQFDKN | 211 | P78369 | |
| ESFFVQKLKGFKASR | 3021 | Q12830 | |
| ENKGFFSFFQRSKKK | 236 | Q53SF7 | |
| KVQFDGTNSAFKELK | 606 | Q8WWK9 | |
| FKSNFSEKASKFGNT | 1841 | P49792 | |
| SEKASKFGNTEQGFK | 1846 | P49792 | |
| KAFTKEFTTGENFKG | 146 | Q6ZRP7 | |
| FKSQNNGFLTDAKEK | 136 | Q6ZSG2 | |
| NNVFKDFLKEFNNKT | 241 | P23458 | |
| ETEKSFKDFQKGFSS | 116 | Q8IXS6 | |
| TTFDTAFFNQGKQTK | 116 | Q9HCM3 | |
| SIFKVADFKNKSKGN | 781 | Q4KMQ2 | |
| KVTQNLANFAKFGSK | 556 | Q5VWQ8 | |
| FGKVFLAEFKKTNQF | 391 | Q04759 | |
| KTNFVGKIKDVVFFQ | 3126 | Q5T1H1 | |
| EKEGKSNEKNDFTKF | 251 | P83111 | |
| ETVKFKVAFNAFKNK | 471 | P98073 | |
| KAAKGSATKDFSVFF | 276 | O95202 | |
| SKSKSAFEKGNVDVF | 81 | Q8IVV2 | |
| VKVTFFQNGKSKKFS | 161 | P31995 | |
| AKTVKNDNSSRFGKF | 251 | Q7Z406 | |
| TFENFTGGVKKQVNK | 1096 | O15031 | |
| FKKECKEVFAFFSHQ | 831 | Q96JB1 | |
| AATFLKKVAKEFGFQ | 26 | Q8TAT6 | |
| KKVAKEFGFQNNGFS | 31 | Q8TAT6 | |
| NKVSESNGEFFFKSS | 151 | Q9H0H0 | |
| QKQKTNFGSSKFIFE | 136 | O60229 | |
| FQAFSKKFLQVGDAF | 226 | Q86UK5 | |
| KNKFGELFSDFCSKV | 986 | Q93074 | |
| SGFEATINKFDKNFS | 816 | Q9BSJ2 | |
| KLFQFDFTGVSNKTE | 241 | P78334 | |
| ANKDSIGFFIAKFVK | 451 | Q8TEA1 | |
| KENQDTGFKFLFTLF | 231 | Q2PPJ7 | |
| LSKFAEKFQEFKEAA | 96 | Q86YM7 | |
| KAFAGNSKSKVSSQF | 826 | Q01780 | |
| FKDTTKNIFDEKGNK | 536 | Q9ULG6 | |
| KFSGFTFKKKTSSDN | 31 | P54132 | |
| FLDKKGQFKKSDAFV | 416 | Q16696 | |
| FLDDKGQFKKSDAFV | 416 | P20853 | |
| EFKEGKKEFQVSLFQ | 581 | Q13619 | |
| TFDEIFNQFKTFNKG | 801 | P51841 | |
| GFTKRKENSTFFDKK | 326 | Q9NWK9 | |
| KGAKNFFEAKVQALS | 186 | Q9BUP0 | |
| DEAFAIKTKKFSQGS | 1401 | Q9ULL0 | |
| SFTFNSQFEFGKKHK | 196 | O60383 | |
| EFDDKDKQFFKNFAT | 496 | Q8WTQ7 | |
| SSFFDKFFKLDKGQE | 191 | O75363 | |
| QSEKLSKQDFFKGFS | 1286 | O43432 | |
| AKTVKNDNSSRFGKF | 231 | P35580 | |
| DQFKGKTSAVEQTFF | 331 | P54317 | |
| NKDGSIDFNEFLKAF | 621 | O14829 | |
| FKGENQNTKLKFVAA | 321 | Q5HYA8 | |
| IVFFANNRFETGKKK | 176 | O43427 | |
| TVNKAGFAANFFKEE | 561 | O43897 | |
| EFKSDNTVSKKGFKA | 711 | O43897 | |
| NTVSKKGFKAHFFSD | 716 | O43897 | |
| KGQNIFTKEAKLFSF | 906 | Q5K651 | |
| KVKKSFIGQNKSFFG | 161 | Q96T51 | |
| AFVSKSFDQKSKDGN | 6 | O15266 | |
| LKKGNFFFKTQEDKE | 641 | Q562F6 | |
| FKDKFGLFAELNNSD | 201 | Q8WTV0 | |
| DGVVFQFKSSKKSNN | 1356 | O75592 | |
| QFAFNGEFKNKAFAL | 251 | Q9H2U2 | |
| GENIKQFFETIFSKK | 1016 | P0DKV0 | |
| KNITKNVTGFFQSFK | 316 | Q9Y6L6 | |
| TEVSDAKNKAFSKFG | 1106 | Q6Q759 | |
| AKNKAFSKFGSFSAT | 1111 | Q6Q759 | |
| AAKFDTQGKAFVKES | 81 | P52823 | |
| NVSFKKFNIEEFGKT | 771 | Q8NFU7 | |
| AKTVKNDNSSRFGKF | 231 | P35749 | |
| TFQFFKKGQKVGEFS | 76 | P10599 | |
| KKFNGDSKVSISFEN | 101 | O14730 | |
| SAFGLDSFKVKQKFF | 546 | Q9NUW8 | |
| DSFKVKQKFFAGSQE | 551 | Q9NUW8 | |
| DEFKSVSKFKIFNTN | 316 | Q16851 | |
| FTKAKQNKFNESGQF | 111 | Q8N609 | |
| SKEDFVQFTKAAKQS | 1196 | Q8NB66 | |
| FKELKKTNDGNIFFS | 16 | Q9UIV8 | |
| KSDFSEFGAKRKFTQ | 1076 | Q5VZP5 | |
| KKSFGFGKRDFENNS | 146 | Q6UXP9 | |
| IEAGCSVKAFKFFQK | 496 | O95758 | |
| FAEGQTSINKTFKKA | 1026 | Q9BZ95 | |
| PFKINFEKTQTGEKF | 211 | Q9Y2H8 | |
| NNFVEIKGSVFKKFE | 281 | Q6NXT6 | |
| KFVGSFKTKQDFIDL | 101 | Q9NX01 | |
| KSKFNFVKFDGQAVA | 541 | Q502W6 | |
| FQNQKKFGTNFTKLE | 196 | O14530 | |
| KDFNIKLSDFGFSKR | 146 | Q96PF2 | |
| AAGSRNKVQEFKFFT | 1796 | O60293 | |
| KDFPKQFDQVSVFKS | 136 | Q5VZL5 | |
| QKQRTNFGSSKFEFE | 166 | O75962 | |
| LDIFGFENFKKNSFE | 716 | Q8NEV4 | |
| EKKFNSFAEGTFTVF | 846 | Q9NZM1 |